7447
Fiscal year ends August Quarters are offset from the calendar — Q1 is Sep–Nov

NAGAILEBEN Co., Ltd. is a Japanese company engaged in the planning, manufacturing, and sale of medical wear and footwear. The company operates as a single business segment, supplying medical apparel designed for healthcare and care workers. It sources its core medical wear products from its manufacturing subsidiary, Nagai Hakui Kogyo Co., Ltd., and also purchases finished goods from domestic and overseas suppliers for resale. In addition to medical wear, the company sells shoes sourced from general trading partners. The group serves customers in the healthcare and caregiving sectors, providing specialized workwear for medical professionals.

Summarised from the annual report, fiscal year ended Aug 2025

Industry Apparel Manufacturing Homepage nagaileben.co.jp
Sector Consumer Cyclical IR page nagaileben.co.jp
Tags
medical wear, healthcare apparel, care worker uniforms, footwear, workwear, Nagai Hakui Kogyo Co. Ltd.
Press page nagaileben.co.jp/press

Metrics

Valuation  
Market cap ¥ 50.376B
Market cap (USD) $ 316.001M
P/E 18.58
PEG —
P/BV 1.29
P/S 2.93
P/OCF 14.28
P/FCF 15.78
Dividend yield 4.3%
Turnover / mcap —
Returns  
ROE 6.6%
ROI 6.8%
ROIC 6.4%
Profit margin 15.4%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -6.3%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -5.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
Revenue 17.206B 16.984B 16.413B 17.182B 17.745B 17.563B 17.066B 16.786B 17.145B 17.017B 16.538B 16.151B 16.214B 15.625B 15.175B
Net profit 2.65B 2.573B 2.822B 3.226B 3.778B 3.648B 3.474B 3.445B 3.676B 3.673B 3.262B 3.226B 3.224B 3.119B 2.372B
Free cash flow 3.193B 1.792B 2.119B 1.528B 3.327B 4.2B 3.457B 3.197B 3.12B 3.858B 3.396B 2.502B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
Share price 1.702K 2.04K 2.441K 2.208K 1.954K 2.554K 2.724K 2.083K 2.592K 2.748K 2.102K 2.458K 2.026K 1.48K 1.208K
Price performance 12m -0.17 -0.16 0.11 0.13 -0.23 -0.06 0.31 -0.2 -0.06 0.31 -0.14 0.21 0.37 0.23 —

Filed figures

Figure Aug 2017 Aug 2018 Aug 2019 Aug 2020 Aug 2021 Aug 2022 Aug 2023 Aug 2024 Aug 2025 Aug 2026
Balance sheet detail
Trade receivables (JPY) 5.04B 4.82B 5.34B 5.57B 4.78B 8.23B 7.91B 7.71B 6.96B 5.17B
↳ YoY growth +2.2% -4.4% +10.9% +4.4% -14.3% +72.4% -3.9% -2.5% -9.7% -25.7%
↳ 5y CAGR +3.2% -0.6% +10.3% +10.4% +7.6% +4.5% +1.6%
Cash and deposits (JPY) 22.8B 23.9B 25.2B 25.6B 27.9B 28.6B 27.2B 26.3B 24.2B 22.4B
Intangible assets (JPY) 54.5M 44.8M 32.5M 49.5M 43.6M 57M 59.9M 72.6M 167M 249M
Cash flow detail
Operating cash flow (JPY) 3.98B 4.01B 3.43B 3.63B 4.45B 3.44B 1.81B 2.29B 2.18B 3.53B
Purchases of property, plant and equipment (JPY) -103M -879M -231M -146M -239M -94.2M -259M -142M -291M -222M
Purchases of intangible assets (JPY) -18.9M -10.5M -4.37M -32.1M -10.2M -21.4M -25.6M -25.8M -97.7M -113M
Change in receivables (cash effect) (JPY) 116M 272M -520M -219M 890M -479M 67.2M 36.3M 390M 1.35B
Change in inventories (cash effect) (JPY) 36.2M -74.8M -93.1M -152M 16.5M -271M -1.17B -531M -460M -707M
Change in payables (cash effect) (JPY) -133M -4.2M 27.5M 141M -302M 317M -1.48M -308M -532M 8.04M
Dividends paid (cash effect) (JPY) -1.66B -1.99B -1.99B -1.99B -1.97B -1.97B -1.94B -1.93B -1.89B -3.05B
Share buybacks (cash effect) (JPY) — — -197,000 -1.03B -226,000 -1.23B -373M -1.45B -2.18B -2B
Income taxes paid (cash effect) (JPY) -1.73B -1.69B -1.62B -1.52B -1.73B -1.58B -1.62B -1.35B -1.23B -1.1B
Operating cash flow before change in receivables (JPY) 3.86B 3.74B 3.95B 3.85B 3.56B 3.92B 1.75B 2.25B 1.79B 2.17B
Free cash flow (OCF - PPE - intangibles) (JPY) 3.86B 3.12B 3.2B 3.46B 4.2B 3.33B 1.53B 2.12B 1.79B 3.19B
Income detail
Research and development expense (JPY) 175M 175M 181M 165M 188M 187M 200M 193M 191M 190M
↳ 5y CAGR +0.9% +1.6% +1.4% +2.7% +1.3% +2.9% +0.2%
Total comprehensive income (JPY) 3.71B 3.79B 3.35B 3.41B 3.86B 3.45B 3.25B 2.84B 2.65B 2.75B
Comprehensive income to owners (JPY) 3.71B 3.79B 3.35B 3.41B 3.86B 3.45B 3.25B 2.84B 2.65B 2.75B
Reported Nov 22, 2017 Nov 22, 2018 Nov 21, 2019 Nov 19, 2020 Nov 25, 2021 Nov 25, 2022 Nov 24, 2023 Nov 22, 2024 Nov 19, 2025 Nov 18, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

NAGAILEBEN Co., Ltd. (ticker 7447), listed in Japan.

ETFs Holding NAGAILEBEN Co., Ltd.

ETF Weight in ETF Shares Market value As of
DXIV 0.01% 1,900 $ 20.2K Nov 12, 2026
DFIS 0.01% 38,700 $ 411.445K Nov 12, 2026
DFIC 0.00% 21,200 $ 225.391K Nov 12, 2026
DFAX 0.00% 10,000 $ 106.316K Nov 12, 2026
DFAI 0.00% 5,600 $ 59.537K Nov 12, 2026